CODX vs JPM
Co-Diagnostics, Inc. Common Stock (CODX) versus JPMorgan Chase & Co (JPM) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
JPMorgan Chase & Co (JPM) is a banks - diversified company listed on US. It is led by Jamie Dimon.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported JPM revenue for 2025-12-31 was $182.45B. Net income was $57.05B. Revenue was up 2.8% from 2024-12-31 to 2025-12-31. JPM currently screens at market cap $805.69B and trailing P/E 14.2.
CODX currently screens at market cap $31.4M. JPM currently screens at market cap $805.69B and trailing P/E 14.2.
Not investment advice. Open the CODX and JPM stock pages for the full models.
Not investment advice.